Sitavig

Product manufactured by Epi Health, Inc

Application Nr Approved Date Route Status External Links
NDA203791 None Buccal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Sitavig Is Indicated For The Treatment Of Recurrent Herpes Labialis (Cold Sores) In Immunocompetent Adults. Sitavig Is A Deoxynucleoside Analogue Of Dna Polymerase Inhibitor, Indicated For The Treatment Of Recurrent Herpes Labialis (Cold Sores) In Immunocompetent Adults. ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Acyclovir ACYCLOVIR ZINC1530555

Comments